Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.04 |
mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.04 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.05 |